Condition: Primary Aldosteronism · Suprarenalectomy · Super Selective Adrenal Artery Embolization · Sponsor: Xinjiang Medical University
The aim of this study was to compare the efficacy and safety of adrenalectomy and superselective adrenal artery embolization in a prospective, multicenter, randomized controlled study. To provide a new interventional alternative therapy for primary aldosteronism.
This description comes directly from the study's public registry record.
Xiang Xie, PhD · +869914366892 · xiangxie999@sina.com
Changjiang Deng · +869914366892 · 1187229853@qq.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Xinjiang Medical University | Ürümqi, Xinjiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06513585